Takeda Pharmaceutical (TAK) Goodwill & Intangibles (2018 - 2026)

Takeda Pharmaceutical's Goodwill & Intangibles history runs 9 years deep, the most recent figure standing at $58.8 billion for Q1 2026.

• In Q1 2026, Goodwill & Intangibles changed 0.24% year-over-year to $58.8 billion; the TTM figure through Mar 2026 stood at $58.8 billion (changed 0.24% YoY), while the FY2026 annual figure was $61.3 billion, up 4.27% from the prior year.
• Goodwill & Intangibles was $58.8 billion for Q1 2026 at Takeda Pharmaceutical, down from $60.2 billion in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $70.8 billion in Q1 2022 to a low of $58.7 billion in Q1 2025.
• Historically, Goodwill & Intangibles has averaged $63.8 billion across 5 years, with a median of $62.3 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles slipped 14.52% in 2022, then advanced 4.07% in 2023.
• A 5-year view of Goodwill & Intangibles shows it stood at $59.9 billion in 2022, then advanced by 4.07% to $62.3 billion in 2023, then gained by 0.04% to $62.3 billion in 2024, then decreased by 3.35% to $60.2 billion in 2025, then declined by 2.3% to $58.8 billion in 2026.
• The last three Goodwill & Intangibles figures came in at $58.8 billion (Q1 2026), $60.2 billion (Q4 2025), and $59.3 billion (Q3 2025), per Business Quant data.